Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Technology · ·
$18.46
▲ $0.01 (+0.1%)
Market data updated: 09/29 04:02 AM
Fundamentals updated: 09/29/2026
News analyzed: 09/29/2026
Market Cap
$777.17M
Day Range
$18.45 - $18.48
52-Week Range
$9.09 - $18.63
Beta
—
Next Earnings
16.11.2026
Support
$10.44
Resistance
$18.63
VREX is a stock from the Technology sector — Software, hardware, chip, and computing-services companies — revenue tied to the pace of innovation and upgrade cycles.
+53.1% (1Y)
Strengths: 8/31 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🟡 Mixed
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Operating margin stability
Operating margin is stable or improving over time
Quality
Biggest negative driver
DCF Fair Value
Estimated fair value: $1.32 vs. price $18.46 (-92.8%)
Fair Value
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 3 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 3
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
48
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
Not enough data yet to generate this synthesis.
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
34
Quality
58
Value
38
Momentum
50
Risk
56
Sentiment
92
Fundamental
32
Institutional
0
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Everyone's writing about Varex Imaging Corporation. News trend score: 92. Reason: 7 of the last 20 articles are positive, versus 0 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
61
🎯 Conviction (vs. Emotion)
40
Psychology
82
Fundamentals
32
Technical
50
Valuation
38
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
Extreme momentum, price far above its moving average, and a large premium over fair value.
The price rise has far outpaced the actual improvement in fundamental data.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Price (3M)
+77%
Market Narrative
73
Fundamental Reality
40
Narrative Gap
+33
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Walter Bagehot — 83/100
🔴 Weakest match
Charles Mackay — 15/100
Walter Bagehot
Lombard Street (1873)
🟢 83
Strong liquidity — would likely survive a real credit squeeze
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟢 71
Reasonable capital-preservation profile
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟡 63
Mid-cycle — no strong signal either way
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟡 59
Some discount, but not the deep 'net-net' bargain Graham's enterprising bar sets
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 58
No clear trend — Livermore preferred to stay out of this
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟡 51
Moderate — holdable, but not effortless
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 48
Mixed — doesn't clearly pass Graham's tests
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 46
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 46
No clear edge either way
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 39
Doesn't show the stability Smith's long-term case requires
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🔴 30
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🔴 26
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🔴 23
Risk/valuation combination Marks would flag as a caution sign
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🔴 21
Pattern Veblen would flag as growth pursued for its own sake
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🔴 20
Looks late-cycle — the position Marks would treat with extra caution
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🔴 15
Pattern consistent with a crowd delusion Mackay would flag
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Based on the last 288 trading days, calculated from real price data. Click an indicator for details and a chart.
🟡 Indicators are mixed — no clear bias (4 bullish · 6 bearish · 1 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear uptrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
34.4%
Operating Margin
-3.3%
Net Margin
-8.3%
EBITDA Margin
-3.3%
ROE
-14.9%
ROA
-6.3%
ROIC
—
EPS
-$1.70
Cash
$145.00M
Total Debt
$367.50M
Current Ratio
3.43
Debt/Equity
0.78
How is Fair Value calculated? →
Current Price
$18.46
Estimated Fair Value (DCF)
$1.32
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
-92.8%
🔴 Appears expensive relative to estimated value
Year 1 Growth Rate
-0.4%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | -0.4% | $18.73M | $17.18M |
| 2 | 0.3% | $18.79M | $15.82M |
| 3 | 1.1% | $18.99M | $14.67M |
| 4 | 1.8% | $19.33M | $13.70M |
| 5 | 2.5% | $19.82M | $12.88M |
Base FCF (last actual year)
$18.80M
Terminal Value
$312.47M
Present Value of Terminal Value
$203.09M
Enterprise Value
$277.33M
Net Debt
$222.50M
Equity Value
$54.83M
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$11.42
Tangible Book Value per Share (Tangible NAV)
$6.29
Sentiment based on basic keywords (not AI) — 7 positive, 13 neutral, 0 negative out of the last 20 articles.
Benzinga · 16.9.2026
Insider Monkey · 26.8.2026
Zacks · 24.8.2026
Zacks · 18.8.2026
SeekingAlpha · 15.8.2026
Insider Monkey · 14.8.2026
Benzinga · 14.8.2026
Simply Wall St. · 12.8.2026
SeekingAlpha · 11.8.2026
MT Newswires · 11.8.2026
MT Newswires · 11.8.2026
Medical Device Network · 11.8.2026
MedTech Dive · 11.8.2026
SeekingAlpha · 11.8.2026
Benzinga · 11.8.2026
Benzinga · 11.8.2026
MT Newswires · 10.8.2026
ChartMill · 10.8.2026
ChartMill · 10.8.2026
ChartMill · 10.8.2026
Varex Imaging Corporation (VREX) currently has a StockIQ AI score of 48/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
VREX currently scores 48/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, VREX's estimated fair value is $1.32, which is 92.8% below the current price of $18.46. This is one valuation model among several signals in the fair-value category, not a price target.
VREX's technical score is 50/100, which currently reads as neutral — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Operating margin is stable or improving over time; ATR: 0.6% of price; Current ratio: 3.43.
Based on the real signals StockIQ computed: Estimated fair value: $1.32 vs. price $18.46 (-92.8%); Operating margin: -3.3% (negative); Net margin: -8.3% (negative).
StockIQ has no recorded dividend payment history for VREX.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 4 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Kunkel Jay K. | Open Market Sale | 14.9.2026 | 15,329 | -8,121 | $18.48 |
| Maheshwari Shubham | Exercise of Derivative Securities | 11.9.2026 | 269,972 | +160,944 | $13.61 |
| Maheshwari Shubham | Open Market Sale | 11.9.2026 | 139,972 | -130,000 | $18.46 |
| Maheshwari Shubham | Exercise of Derivative Securities | 11.9.2026 | 0 | -160,944 | — |
| Aranki Karen L | Exercise of Derivative Securities | 14.8.2026 | 8,893 | +3,974 | — |
| Aranki Karen L | Exercise of Derivative Securities | 14.8.2026 | 3,975 | -3,974 | — |
| Aranki Karen L | Tax Withholding in Shares | 14.8.2026 | 7,748 | -1,145 | $18.49 |
| Aranki Karen L | Exercise of Derivative Securities | 14.8.2026 | 3,974 | +3,974 | — |
| Aranki Karen L | Exercise of Derivative Securities | 14.8.2026 | 3,974 | -3,974 | — |
| Aranki Karen L | Tax Withholding in Shares | 14.8.2026 | 1,145 | -1,145 | $18.49 |
| Kunkel Jay K. | Open Market Sale | 20.3.2026 | 4,510 | -4,510 | $11.14 |
| Kunkel Jay K. | Open Market Sale | 20.3.2026 | 23,450 | -4,510 | $11.14 |
| GUERTIN TIMOTHY E | Grant/Award from Employer | 12.2.2026 | 12,331 | +12,331 | — |
| Bardwell Kathleen | Grant/Award from Employer | 12.2.2026 | 12,331 | +12,331 | — |
| Rosebrough Walter M Jr | Grant/Award from Employer | 12.2.2026 | 14,947 | +14,947 | — |
| Kunkel Jay K. | Grant/Award from Employer | 12.2.2026 | 12,331 | +12,331 | — |
| TSINGOS CHRISTINE A | Grant/Award from Employer | 12.2.2026 | 12,331 | +12,331 | — |
| Chertoff Jocelyn D | Grant/Award from Employer | 12.2.2026 | 12,331 | +12,331 | — |
| GUERTIN TIMOTHY E | Grant/Award from Employer | 12.2.2026 | 12,331 | +12,331 | — |
| TSINGOS CHRISTINE A | Grant/Award from Employer | 12.2.2026 | 12,331 | +12,331 | — |
| Rosebrough Walter M Jr | Grant/Award from Employer | 12.2.2026 | 14,947 | +14,947 | — |
| Bardwell Kathleen | Grant/Award from Employer | 12.2.2026 | 12,331 | +12,331 | — |
| Kunkel Jay K. | Grant/Award from Employer | 12.2.2026 | 12,331 | +12,331 | — |
| Chertoff Jocelyn D | Grant/Award from Employer | 12.2.2026 | 12,331 | +12,331 | — |
| Rosebrough Walter M Jr | Exercise of Derivative Securities | 9.2.2026 | 10,339 | -10,339 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
1,405,135 shares short as of 2026-09-15 · vs. 1,253,607 on 2026-08-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
47.2% of trading volume this week was short selling, vs. 30.5% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology